Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

50

Revenue 2017

Levemir

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Levemir was produced by Novo Nordisk.

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity

Xultophy’s performance helped prop up the insulin category as it copes with a slide in sales of top seller Levemir (insulin detemir), which shrank by almost a quarter to

Novo says real-world data backs its insulin switching

Novo says real-world data backs its insulin switching It showed that switching to Tresiba (insulin from another basal insulin - mainly Sanofi's Lantus (insulin glargine U100) or Novo's own Levemir (insulin detemir) brand - improved blood glucose control and

Lilly and Boehringer launch first Lantus clone Basaglar in US

Lilly and Boehringer launch first Lantus clone Basaglar in US Nordisk's Levemir (insulin detemir) and Tresiba (insulin degludec). ... The list price of Basaglar in the US is $316.85 for a pack of five autoinjector pens, which also undercuts Sanofi's Lantus follow-up Toujeo, as well as Levemir

Sanofi fires off another lawsuit against a Lantus biosimilar

Sanofi fires off another lawsuit against a Lantus biosimilar Lantus made more than $7bn in sales last year but is already showing the effects of competition from biosimilars and other branded basal insulin rivals such as Novo Nordisk's Levemir

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics